The Personalised Randomised Controlled Trial (PRACTical): evaluation of a new trial design
In some clinical scenarios, for example, severe sepsis caused by extensively drug resistant bacteria, there is uncertainty between many common treatments, but a conventional multiarm randomized trial is not possible because individual participants may not be eligible to receive certain treatments. T...
Main Authors: | Lee, KM, Turner, RM, Thwaites, GE, Walker, AS, White, IR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2023
|
Similar Items
-
Personalised randomised controlled trial designs – a new paradigm to define optimal treatments for carbapenem-resistant infections
by: Walker, AS, et al.
Published: (2021) -
Determining sample size in a personalized randomized controlled (PRACTical) trial
by: Turner, RM, et al.
Published: (2024) -
Cost-effectiveness of the PDSAFE personalised physiotherapy intervention for fall prevention in Parkinson's: an economic evaluation alongside a randomised controlled trial
by: Xin, Y, et al.
Published: (2020) -
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial
by: Torben Hansen, et al.
Published: (2024-02-01) -
When should factorial designs be used for late-phase randomised controlled trials?
by: White, IR, et al.
Published: (2023)